{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:07:52Z","timestamp":1790032072320,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77089-9","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:23:23Z","timestamp":1787358203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alcohol reshapes liver zonal plasticity and immune-metabolic reprogramming in metabolic-syndrome associated hepatocellular carcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Tian","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-4566","authenticated-orcid":false,"given":"Chunbao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-0399","authenticated-orcid":false,"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-4336","authenticated-orcid":false,"given":"Jinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0653-7693","authenticated-orcid":false,"given":"Brady","family":"Jin-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9821-9935","authenticated-orcid":false,"given":"Joshua M.","family":"Barkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Nzegwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-7395","authenticated-orcid":false,"given":"Lin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-372X","authenticated-orcid":false,"given":"Huiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-2064","authenticated-orcid":false,"given":"Bilon","family":"Khambu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-6093","authenticated-orcid":false,"given":"Xiao-Ming","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2400-6461","authenticated-orcid":false,"given":"Daohong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3939-3569","authenticated-orcid":false,"given":"Anastasia G.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongtao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4012-9557","authenticated-orcid":false,"given":"Shengmin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-2617","authenticated-orcid":false,"given":"Lizi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryon","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6812-1816","authenticated-orcid":false,"given":"Ali","family":"Zarrinpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-5697","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-7677","authenticated-orcid":false,"given":"Liya","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"77089_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1177\/1535370217707731","volume":"242","author":"A Soto-Gutierrez","year":"2017","unstructured":"Soto-Gutierrez, A., Gough, A., Vernetti, L. A., Taylor, D. L. & Monga, S. P. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: the potential of microphysiology systems. Exp. Biol. Med. 242, 1605\u20131616 (2017).","journal-title":"Exp. Biol. Med."},{"key":"77089_CR2","doi-asserted-by":"crossref","unstructured":"Wei, Y. et al. Liver homeostasis is maintained by midlobular zone 2 hepatocytes. Science 371, eabb1625 (2021).","DOI":"10.1126\/science.abb1625"},{"key":"77089_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41588-023-01335-9","volume":"55","author":"W Pu","year":"2023","unstructured":"Pu, W. et al. Bipotent transitional liver progenitor cells contribute to liver regeneration. Nat. Genet 55, 651\u2013664 (2023).","journal-title":"Nat. Genet"},{"key":"77089_CR4","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/hep.29254","volume":"66","author":"R Desert","year":"2017","unstructured":"Desert, R. et al. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection. Hepatology 66, 1502\u20131518 (2017).","journal-title":"Hepatology"},{"key":"77089_CR5","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41416-024-02849-7","volume":"131","author":"C Dantzer","year":"2024","unstructured":"Dantzer, C. et al. Specific features of ss-catenin-mutated hepatocellular carcinomas. Br. J. Cancer 131, 1871\u20131880 (2024).","journal-title":"Br. J. Cancer"},{"key":"77089_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.adv7129","volume":"391","author":"J Guo","year":"2026","unstructured":"Guo, J. et al. The origin of hepatocellular carcinoma depends on metabolic zonation. Science 391, eadv7129 (2026).","journal-title":"Science"},{"key":"77089_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jhep.2022.03.015","volume":"77","author":"AM Wong","year":"2022","unstructured":"Wong, A. M. et al. Unique molecular characteristics of NAFLD-associated liver cancer accentuate beta-catenin\/TNFRSF19-mediated immune evasion. J. Hepatol. 77, 410\u2013423 (2022).","journal-title":"J. Hepatol."},{"key":"77089_CR8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","volume":"9","author":"M Ruiz de Galarreta","year":"2019","unstructured":"Ruiz de Galarreta, M. et al. beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. Cancer Discov. 9, 1124\u20131141 (2019).","journal-title":"Cancer Discov."},{"key":"77089_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60457-2","volume":"16","author":"BM Lehrich","year":"2025","unstructured":"Lehrich, B. M. et al. Precision targeting of beta-catenin induces tumor reprogramming and immunity in hepatocellular cancers. Nat. Commun. 16, 5009 (2025).","journal-title":"Nat. Commun."},{"key":"77089_CR10","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann, D. et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell 186, 5068\u20135083 (2023).","journal-title":"Cell"},{"key":"77089_CR11","doi-asserted-by":"publisher","first-page":"0270","DOI":"10.1097\/HEP.0000000000000786","volume":"82","author":"X Wang","year":"2025","unstructured":"Wang, X., Zhang, L. & Dong, B. Molecular mechanisms in MASLD\/MASH-related HCC. Hepatology 82, 0270\u20139139 (2025).","journal-title":"Hepatology"},{"key":"77089_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41586-024-08317-9","volume":"637","author":"L Gu","year":"2025","unstructured":"Gu, L. et al. FBP1 controls liver cancer evolution from senescent MASH hepatocytes. Nature 637, 461\u2013469 (2025).","journal-title":"Nature"},{"key":"77089_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister, D. et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592, 450\u2013456 (2021).","journal-title":"Nature"},{"key":"77089_CR14","doi-asserted-by":"crossref","unstructured":"Cheu, J. W. & Wong, C. C. The immune microenvironment of steatotic hepatocellular carcinoma: Current findings and future prospects. Hepatol. Commun. 8, e0516 (2024).","DOI":"10.1097\/HC9.0000000000000516"},{"key":"77089_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/gutjnl-2013-305718","volume":"63","author":"S Sookoian","year":"2014","unstructured":"Sookoian, S., Castano, G. O. & Pirola, C. J. Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. Gut 63, 530\u2013532 (2014).","journal-title":"Gut"},{"key":"77089_CR16","first-page":"568","volume":"34","author":"K Wijarnpreecha","year":"2021","unstructured":"Wijarnpreecha, K. et al. Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann. Gastroenterol. 34, 568\u2013574 (2021).","journal-title":"Ann. Gastroenterol."},{"key":"77089_CR17","doi-asserted-by":"publisher","first-page":"E9879","DOI":"10.1073\/pnas.1811029115","volume":"115","author":"M Dow","year":"2018","unstructured":"Dow, M. et al. Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 115, E9879\u2013E9888 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77089_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","volume":"46","author":"M Fujii","year":"2013","unstructured":"Fujii, M. et al. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Med. Mol. Morphol. 46, 141\u2013152 (2013).","journal-title":"Med. Mol. Morphol."},{"key":"77089_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajpath.2025.04.016","volume":"196","author":"Y Xue","year":"2026","unstructured":"Xue, Y. et al. Alcohol-associated hepatocarcinogenesis: Wnt\/beta-Catenin in action. Am. J. Pathol. 196, 151\u2013160 (2026).","journal-title":"Am. J. Pathol."},{"key":"77089_CR20","doi-asserted-by":"publisher","first-page":"0270","DOI":"10.1002\/hep.28638","volume":"64","author":"S Rebouissou","year":"2016","unstructured":"Rebouissou, S. et al. Genotype-phenotype correlation of CTNNB1 mutations reveals different \u00df-catenin activity associated with liver tumor progression. Hepatology 64, 0270\u20139139 (2016).","journal-title":"Hepatology"},{"key":"77089_CR21","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","volume":"69","author":"Y Hoshida","year":"2009","unstructured":"Hoshida, Y. et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 69, 7385\u20137392 (2009).","journal-title":"Cancer Res."},{"key":"77089_CR22","doi-asserted-by":"crossref","unstructured":"Chen, C. T. et al. Aberrant upregulation of indoleamine 2,3-dioxygenase 1 promotes proliferation and metastasis of hepatocellular carcinoma cells via coordinated activation of AhR and beta-catenin signaling. Int. J. Mol. Sci. 22, 11661 (2021).","DOI":"10.3390\/ijms222111661"},{"key":"77089_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-213X-10-121","volume":"10","author":"A Ferrer-Vaquer","year":"2010","unstructured":"Ferrer-Vaquer, A. et al. A sensitive and bright single-cell resolution live imaging reporter of Wnt\/ss-catenin signaling in the mouse. BMC Dev. Biol. 10, 121 (2010).","journal-title":"BMC Dev. Biol."},{"key":"77089_CR24","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ijc.28798","volume":"135","author":"EB Unterberger","year":"2014","unstructured":"Unterberger, E. B. et al. Ha-ras and beta-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors. Int. J. Cancer 135, 1574\u20131585 (2014).","journal-title":"Int. J. Cancer"},{"key":"77089_CR25","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1053\/j.gastro.2008.07.012","volume":"135","author":"S Ladu","year":"2008","unstructured":"Ladu, S. et al. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA\/Akt\/mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology 135, 1322\u20131332 (2008).","journal-title":"Gastroenterology"},{"key":"77089_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature21065","volume":"542","author":"KB Halpern","year":"2017","unstructured":"Halpern, K. B. et al. Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542, 352\u2013356 (2017).","journal-title":"Nature"},{"key":"77089_CR27","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.7150\/jca.78098","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang, D., Li, J. & Li, W. LHPP suppresses gastric cancer progression via the PI3K\/AKT\/mTOR signaling pathway. J. Cancer 13, 3584\u20133592 (2022).","journal-title":"J. Cancer"},{"key":"77089_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1053\/j.gastro.2019.07.030","volume":"157","author":"Y Luo","year":"2019","unstructured":"Luo, Y. et al. Oncogenic KRAS reduces expression of FGF21 in acinar cells to promote pancreatic tumorigenesis in mice on a high-fat diet. Gastroenterology 157, 1413\u20131428 e1411 (2019).","journal-title":"Gastroenterology"},{"key":"77089_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s42003-024-06202-9","volume":"7","author":"S Nakagawa","year":"2024","unstructured":"Nakagawa, S. et al. Wnt\/beta-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and FOXA1 in liver cancer cells. Commun. Biol. 7, 510 (2024).","journal-title":"Commun. Biol."},{"key":"77089_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2019.06.018","volume":"71","author":"W Seo","year":"2019","unstructured":"Seo, W. et al. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles. J. Hepatol. 71, 1000\u20131011 (2019).","journal-title":"J. Hepatol."},{"key":"77089_CR31","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.3748\/wjg.v18.i34.4751","volume":"18","author":"JI Lee","year":"2012","unstructured":"Lee, J. I. et al. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers. World J. Gastroenterol. 18, 4751\u20134757 (2012).","journal-title":"World J. Gastroenterol."},{"key":"77089_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27210-x","volume":"12","author":"D Lv","year":"2021","unstructured":"Lv, D. et al. Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat. Commun. 12, 6896 (2021).","journal-title":"Nat. Commun."},{"key":"77089_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation. Cancer Cell 33, 480\u2013494 e487 (2018).","journal-title":"Cancer Cell"},{"key":"77089_CR34","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1007\/s10620-015-3632-x","volume":"60","author":"T Ji","year":"2015","unstructured":"Ji, T. et al. Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of DSS-induced colitis. Dig. Dis. Sci. 60, 1958\u20131966 (2015).","journal-title":"Dig. Dis. Sci."},{"key":"77089_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/cmi.2014.49","volume":"12","author":"L Hou","year":"2015","unstructured":"Hou, L. et al. Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis. Cell Mol. Immunol. 12, 213\u2013221 (2015).","journal-title":"Cell Mol. Immunol."},{"key":"77089_CR36","doi-asserted-by":"crossref","unstructured":"Hsu, Y. C. et al. Ethanol inhibits the growth and metastasis of hepatocellular carcinoma by inducing immunogenic cell death. J. Immunother. Cancer 13, e010472 (2025).","DOI":"10.1136\/jitc-2024-010472"},{"key":"77089_CR37","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Therapeutic values of myeloid-derived suppressor cells in hepatocellular carcinoma: facts and hopes. Cancers 13, 5127 (2021).","DOI":"10.3390\/cancers13205127"},{"key":"77089_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100780","volume":"5","author":"KL Thomsen","year":"2023","unstructured":"Thomsen, K. L. et al. Role of ammonia in NAFLD: an unusual suspect. JHEP Rep. 5, 100780 (2023).","journal-title":"JHEP Rep."},{"key":"77089_CR39","doi-asserted-by":"crossref","unstructured":"Dai, W. et al. Glutamine synthetase limits beta-catenin-mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1. J. Clin. Invest. 132, e161408 (2022).","DOI":"10.1172\/JCI161408"},{"key":"77089_CR40","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","volume":"73","author":"Q Huang","year":"2013","unstructured":"Huang, Q. et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 73, 4992\u20135002 (2013).","journal-title":"Cancer Res."},{"key":"77089_CR41","doi-asserted-by":"crossref","unstructured":"Casadei-Gardini, A. et al. (1)H-NMR based serum metabolomics highlights different specific biomarkers between early and advanced hepatocellular carcinoma stages. Cancers 12, 241 (2020).","DOI":"10.3390\/cancers12010241"},{"key":"77089_CR42","doi-asserted-by":"publisher","first-page":"e0241002","DOI":"10.1371\/journal.pone.0241002","volume":"15","author":"S Bekki","year":"2020","unstructured":"Bekki, S. et al. Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma. PLoS ONE 15, e0241002 (2020).","journal-title":"PLoS ONE"},{"key":"77089_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42334-y","volume":"14","author":"K Soeda","year":"2023","unstructured":"Soeda, K. et al. Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis. Nat. Commun. 14, 6584 (2023).","journal-title":"Nat. Commun."},{"key":"77089_CR44","first-page":"1786","volume":"13","author":"X Li","year":"2023","unstructured":"Li, X. et al. Alcohol remodels the immunosuppressive tumor microenvironment by targeting myeloid-derived suppressor cells. Am. J. Cancer Res. 13, 1786\u20131805 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"77089_CR45","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.gastro.2014.11.041","volume":"148","author":"LJ Markwick","year":"2015","unstructured":"Markwick, L. J. et al. Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis. Gastroenterology 148, 590\u2013602 e510 (2015).","journal-title":"Gastroenterology"},{"key":"77089_CR46","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.3892\/mmr.2017.6435","volume":"15","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Constitutive androstane receptor activation promotes bilirubin clearance in a murine model of alcoholic liver disease. Mol. Med. Rep. 15, 3459\u20133466 (2017).","journal-title":"Mol. Med. Rep."},{"key":"77089_CR47","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.ajpath.2018.07.022","volume":"188","author":"S Mattu","year":"2018","unstructured":"Mattu, S. et al. High frequency of beta-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist. Am. J. Pathol. 188, 2497\u20132507 (2018).","journal-title":"Am. J. Pathol."},{"key":"77089_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41590-018-0290-0","volume":"20","author":"WC Cheng","year":"2019","unstructured":"Cheng, W. C. et al. Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle. Nat. Immunol. 20, 206\u2013217 (2019).","journal-title":"Nat. Immunol."},{"key":"77089_CR49","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41366-019-0512-z","volume":"44","author":"IY Rojas","year":"2020","unstructured":"Rojas, I. Y., Moyer, B. J., Ringelberg, C. S. & Tomlinson, C. R. Reversal of obesity and liver steatosis in mice via inhibition of aryl hydrocarbon receptor and altered gene expression of CYP1B1, PPARalpha, SCD1, and osteopontin. Int. J. Obes. 44, 948\u2013963 (2020).","journal-title":"Int. J. Obes."},{"key":"77089_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47687-6","volume":"15","author":"W Yang","year":"2024","unstructured":"Yang, W. et al. An estrogen receptor alpha-derived peptide improves glucose homeostasis during obesity. Nat. Commun. 15, 3410 (2024).","journal-title":"Nat. Commun."},{"key":"77089_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47799-w","volume":"9","author":"R Endo","year":"2019","unstructured":"Endo, R., Nakamura, T., Kawakami, K., Sato, Y. & Harashima, H. The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy. Sci. Rep. 9, 11335 (2019).","journal-title":"Sci. Rep."},{"key":"77089_CR52","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 e1821 (2019).","journal-title":"Cell"},{"key":"77089_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"77089_CR54","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS ONE 18, e0294236 (2023).","journal-title":"PLoS ONE"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77089-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:40:35Z","timestamp":1790030435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77089-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77089"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77089-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.P. and D.Z. are inventors on the patent for mouse models of alcohol-induced liver cancer. The other authors declare no conflicts of interest regarding the publication of this manuscript.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10047"}}